Luminate Medical

Therapeutic Devices · Galway, Ireland · Founded 2019 · Privately Held (backing)

Developer of novel devices designed to make cancer care better for patients. Luminate Medical is based in Galway, Ireland and was founded in 2019. It was valued at $74.5 million at its later-stage round in Jan 2026, the last priced event on record. It has raised $34.6 million across 2 recorded rounds; the latest was a $21 million Series A in Jan 2026.

PMV mark · valuation
$74.5M
Oct 2026
Priced at
its later-stage round
Jan 2026
Total raised
$34.6M
Last round
Later Stage VC (Series A)
Jan 2026
What is Luminate Medical worth?
$74.5MPrivateMarketView mark · Oct 2026

Valued at $74.5M at its later-stage round, Jan 2026. Nothing has traded since.

Free account
More of Luminate Medical with a free account
  • ·The complete investor list: 23 names
  • ·Watch Luminate Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Luminate Medical funding history

2 rounds
DateRoundRaisedPost-money
Jan 2026Later Stage VC (Series A)$21.0M▮
May 2024Later Stage VC (Series A)$13.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Luminate Medical valuation

Luminate Medical was valued at $74.5 million at its later-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Luminate Medical raised?

Luminate Medical has raised $34.6 million across 2 recorded rounds since 2024. The largest was a $21 million Series A in Jan 2026.

Luminate Medical has filed 3 Form Ds with the SEC since 2024, most recently in Nov 2025 ($17 million sold to 18 investors).

Comparable companies

Comparable therapeutic devices names by valuation on PrivateMarketView: Eyconis ($161 million), Materna Medical ($110 million) and Osteoboost ($45 million).

How Luminate Medical's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Luminate Medical, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Luminate Medical

What is Luminate Medical worth?
Luminate Medical is valued at $74.5M as of Oct 2026. Valued at $74.5M at its later-stage round, Jan 2026. Nothing has traded since.
How much has Luminate Medical raised?
Luminate Medical has raised $34.6M in total funding across 2 recorded rounds.
When did Luminate Medical last raise?
Luminate Medical last raised in Jan 2026 (Later Stage VC (Series A)), raising $21.0M.